The outgoing surgeon general will have to rely on Congress and the next administration to add warnings about cancer risks to ...

As a chronic pain patient, I have experienced the anguish and degradation of being denied pain medication firsthand,” a STAT reader writes.

The explosive rise of GLP-1 drugs like Ozempic has brought an accompanying challenge: logistics too knotty for a single ...

Trump's staff is laying the groundwork to prepare for a new FDA commissioner and make their mark at the agency.

The U.S. surgeon general on Friday called for alcoholic beverages to carry labels warning of their connection to cancer, just ...

Snake oil, it turns out, motivated the founding of the FDA. The term “snake oil” arose out of a controversy from the late ...

The alcohol industry relies on the myth of “responsible enjoyment” to downplay its products’ risks while spreading misinformation to stifle regulation.

The updates are fairly straightforward. The government is requiring hospitals to include additional pieces of data to improve ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Happy New Year, biotech ...

Former President Jimmy Carter, who died Sunday at age 100, gave visibility to devastating health problems that are often ...

The devices remain unreliable in darker skinned people. Researchers say more guidance, enforcement and even legal action may ...

The CDC said Thursday that the mutations, detected in a sample taken from a Louisiana patient, may help bind the virus to the ...